Active and passive immunization against Clostridium difficile diarrhea and colitis.
Clostridium difficile, a gram-positive bacterium, is the major cause of hospital-acquired infectious diarrhea and colitis in industrialized nations. C. difficile colonization results from antibiotic administration and subsequent loss of protection provided by intestinal flora. C. difficile induced-colitis is caused by the release of two exotoxins, toxin A and B. Host factors including advanced age, pre-existing severe illness and weakened immune defenses predispose individuals to symptomatic infection. The generation of antibody responses to toxin A through natural exposure is associated with protection from disease. In addition, an inability to acquire immunity to toxin A puts individuals at risk for recurrent and/or severe disease. Immunological approaches for the management of this disease are being developed which could reduce the reliance on antibiotics for treatment and allow for re-establishment of the natural barrier provided by an intact commensal flora. An active vaccine and various immunotherapeutic strategies under evaluation may prove to be effective against severe or relapsing C. difficile infection.
Giannasca
Paul J
PJ
Acambis Inc., 38 Sidney Street, Cambridge, MA 02139, USA. paul.giannasca@acambis.com
Warny
Michel
M
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis / Q000096:biosynthesis; D001426:Bacterial Proteins; D001427:Bacterial Toxins / Q000276:immunology; D016360:Clostridioides difficile / Q000276:immunology*; D003967:Diarrhea / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive; D012307:Risk Factors; D014611:Vaccination
D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D001427:Bacterial Toxins; C031815:toxB protein, Clostridium difficile